Editorials Societal responsibilities of clinical trial sponsors BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7286.569 (Published 10 March 2001) Cite this as: BMJ 2001;322:569 Article Related content Metrics Responses Peer review Related articles Editor's Choice Delivering drugs and making the BMJ less boring Published: 10 March 2001; BMJ 322 doi:10.1136/bmj.322.7286.0/a Editor's Choice Delivering drugs and making the BMJ less boring Published: 10 March 2001; BMJ 322 doi:10.1136/bmj.322.7286.0 Education And Debate Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibilityCommentary: Early discontinuation violates Helsinki principles Published: 10 March 2001; BMJ 322 doi:10.1136/bmj.322.7286.603 See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 NHS to fund large trial of pre-exposure prophylaxis for HIV prevention BMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis BMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112 Sixty seconds on . . . solanezumab BMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389 Cited by... When Business and Science Clash, How Can We Avoid Harming Patients?: The Case of AVOID-HFFulltext PDF Commercially Funded and United States-Based Research Is More Likely to Be Published; Good-Quality Studies with Negative Outcomes Are NotFulltext PDF Abstract Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compassFulltext PDF Abstract Institutional ethics review of clinical study agreementsFulltext PDF Abstract Responsibilities of sponsors are limited in premature discontinuation of trialsFulltext PDF Abstract